Noon Market Summary: S&P 500 Falls 1.18% as Gold Surges 2.68% Amid Trump Tariff Uncertainty

The U.S. market opened with a bearish tone at noon, as major indexes tumbled amid renewed uncertainty over President Trump’s 15% global tariff policy. The S&P 500 (SPX) dropped 1.177% to 6,828.18, the Nasdaq Composite (IXIC) fell 1.361% to 22,574.60, and the Dow Jones Industrial (DJI) slumped 1.579% to 48,842.20. Commodities saw mixed results: gold futures surged 2.681% to $5,217.1, while WTI crude oil rose 0.827% to $67.03. Sectors were split, with Energy (+0.31%) and Consumer Staples (+1.04%) outperforming, while Financials (-2.28%) and Industrials (-1.51%) led declines. The market’s mixed sentiment reflects investor caution over Trump’s tariff strategy and geopolitical tensions.

Hot Stocks

Tech Giants:

• Tesla (TSLA): -2.49%
• Microsoft (MSFT): -2.65%
• Amazon.com (AMZN): -2.73%
• Meta (META): -1.54%
• Apple (AAPL): +0.81%
• Nvidia (NVDA): +0.46%

Chinese ADRs & Biotech:

• Tian Ruixiang (TIRX): +141.14%
• Arcellx (ACLX): +77.52%
• J-Star Holding (YMAT): +75.70%
• Allurion (ALUR): +46.33%
• Vanda Pharmaceuticals (VNDA): +42.37%

Losers:

• Toast (TOST): -6.02%
• Hyatt Hotels (H): -5.81%
• Sowell (LHSW): -10.80%
• Algorhythm Holdings (RIME): -11.68%

Macro & Corporate & Global Narrative

1. Trump’s Tariff Uncertainty Sparks Global Trade Chaos

President Trump’s 15% global tariff, imposed under Section 122 of the Trade Act, triggered immediate market volatility. The Supreme Court’s recent invalidation of his prior emergency-powers-based tariffs has left $175 billion in potential refunds for importers, while the EU suspended ratification of its U.S. trade deal. European officials warned of retaliatory measures, with Switzerland and the UK expressing concerns over rising effective tariffs. The policy shift has also disrupted private equity, with returns lagging for four consecutive years due to frozen dealmaking.

2. Novo Nordisk’s Weight-Loss Drug Setback Shakes Biotech

Novo Nordisk’s shares fell 10% after its CagriSema trial showed 23% weight loss, underperforming Eli Lilly’s Zepbound (25.5%). The result has shifted investor focus to M&A, with analysts estimating up to $35 billion in potential acquisitions this year. Eli Lilly’s stock rose 2.1% premarket as it solidified its market leadership in the obesity drug sector.

3. Gilead Acquires Arcellx for $7.8 Billion to Bolster Oncology Portfolio

Gilead Sciences agreed to acquire Arcellx for $7.8 billion, including a contingent payment tied to sales of its experimental CAR-T therapy, anito-cel. The deal, a 79% premium to Arcellx’s stock price, highlights the biotech sector’s consolidation trend. Arcellx’s shares surged 77.8% premarket, while Gilead fell 1% as investors weighed the acquisition’s long-term impact.

4. Supreme Court Ruling Reshapes U.S.-China Trade Dynamics

The Supreme Court’s rejection of Trump’s emergency tariffs reduced China’s average U.S. tariff from 32% to 24%, temporarily easing trade tensions. However, Trump’s new 15% global tariff has shifted the balance in China’s favor, with analysts noting its $1.2 trillion trade surplus and rare earths dominance. The ruling also weakened U.S. leverage in negotiations with Beijing ahead of Trump’s planned summit.

5. Private Equity Sector Faces Worst Returns Since 2008

Trump’s tariff policies have caused private equity returns to lag for four consecutive years, with firms distributing only 14% of net asset value to investors in 2025. The sector faces challenges from high interest rates, reduced deal activity, and a $3.8 trillion backlog of unsold investments. The “Liberation Day” tariff announcement in April 2024 froze dealmaking for months, exacerbating the downturn.

6. ExxonMobil Seeks $1 Billion in Compensation from Cuba

The Supreme Court will hear arguments on the Helms-Burton Act, which allows U.S. companies to sue over property seized by Cuba. ExxonMobil seeks over $1 billion in compensation for assets confiscated in 1960, while a separate case involves cruise operators liable for using docks built by a U.S. company also seized by Cuba. The cases test the law’s reach and could set a precedent for future claims.